BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15026367)

  • 1. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
    Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
    Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.
    Rajah R; Valentinis B; Cohen P
    J Biol Chem; 1997 May; 272(18):12181-8. PubMed ID: 9115291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells.
    Butt AJ; Dickson KA; Jambazov S; Baxter RC
    Endocrinology; 2005 Jul; 146(7):3113-22. PubMed ID: 15802501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
    Schmid C; Ghirlanda-Keller C; Zapf J
    Eur J Endocrinol; 2001 Aug; 145(2):213-21. PubMed ID: 11454519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
    Hong J; Zhang G; Dong F; Rechler MM
    J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.
    Hochscheid R; Jaques G; Wegmann B
    J Endocrinol; 2000 Sep; 166(3):553-63. PubMed ID: 10974650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.
    Rozen F; Zhang J; Pollak M
    Int J Oncol; 1998 Oct; 13(4):865-9. PubMed ID: 9735418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling.
    Han J; Jogie-Brahim S; Harada A; Oh Y
    Cancer Lett; 2011 Aug; 307(2):200-10. PubMed ID: 21536375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
    Kimura G; Kasuya J; Giannini S; Honda Y; Mohan S; Kawachi M; Akimoto M; Fujita-Yamaguchi Y
    Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells.
    Oh Y; Gucev Z; Ng L; Müller HL; Rosenfeld RG
    Prog Growth Factor Res; 1995; 6(2-4):503-12. PubMed ID: 8817695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.
    Lee KW; Ma L; Yan X; Liu B; Zhang XK; Cohen P
    J Biol Chem; 2005 Apr; 280(17):16942-8. PubMed ID: 15731112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.
    Butt AJ; Fraley KA; Firth SM; Baxter RC
    Endocrinology; 2002 Jul; 143(7):2693-9. PubMed ID: 12072403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.